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The Natural History of Peanut and Egg Allergy and Predictors of Persistence: The Healthnuts Longitudinal Study, 6-Year-Old Follow-up. Melbourne School of Population & Global Health, Melbourne, VIC, Australia. RATIONALE: There is little prospectively collected data on the natural history of egg and peanut allergy. We examined whether skin prick test (SPT) thresholds or clinical factors present at diagnosis could predict the persistence or resolution of food allergy in early childhood.
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METHODS:
One-year-old infants with challenge-confirmed peanut (n 5 156) and egg (n 5 468) allergy from the population-based, HealthNuts Study (n 5 5276) underwent follow-up at age 6 year including SPT and oral food challenge (OFC). Children with SPT > _ 8 mm and positive OFC at age 4 years were considered persistent allergic at age 6 without challenge. RESULTS: Peanut allergy resolved in 31% (95% CI 24-40%; n 5 41/131) and egg allergy resolved in 89% (95% CI 85-92%; n 5 284/320) at age 6. At age 6, SPT > _5mm (95% CI 1-7mm) and > _6mm (95% CI 5-7mm) had 95% positive predictive value to persistent peanut and egg allergy, respectively, while SPT < _2mm had 95% or 98% negative predictive value to resolved peanut and egg allergy, respectively. SPT measured at age 1 was a poor predictor of persistent food allergy at age 6 (peanut: AUC 0.65 95%CI 0.55-0.75, egg: AUC 0.69 95%CI 0.59-0.78). Eczema at age 1 was associated with persistent food allergy (peanut: aOR 2.74 (95%CI 1.13-6.62), egg: aOR 3.53 (95%CI 1.31-9.47)); tree nut sensitisation at age 1 year was associated with persistent peanut allergy (aOR 2.63 (95%CI 0.99-6.96)). CONCLUSIONS: We report SPT thresholds at age 6 with 95% PPV to persistent food allergy. SPT at diagnosis was a poorly predictor of persistent food allergy although coexisting allergies at diagnosis were associated with persistent food allergy. Evidence from randomised controlled trials demonstrates that earlier introduction of peanut in infants reduces the risk of peanut allergy. Australian infant feeding guidelines were amended in 2016 to recommend introducing peanut before 12 months. Our previous population-based study in 2007-2011 (HealthNuts, n 5 5,300), found a high prevalence of challenge-confirmed peanut allergy (3.1%, 95%CI 2.7-3.6) with few infants consuming peanut in the first year of life (28%, 95%CI 26.8-29.3). There is no data on peanut introduction or allergy prevalence following the introduction of these guidelines. METHODS: EarlyNuts is a population-based, cross-sectional study of 2,000 12-month-old infants in Melbourne, Australia (2018 -2019 , recruited using an identical sampling frame and methods to the HealthNuts cohort, to facilitate assessment of changes over time. Parents completed a questionnaire and infants underwent skin prick test to peanut, followed by oral food challenge if positive. We report here on the first 787 participants, recruited by October 2018 (response rate 74% -similar to HealthNuts). RESULTS: Most infants (88.7%, 95%CI 86.1-91.0) had introduced peanut by 12 months (median age 6 months). By 12 months, most of these (78%) had consumed peanut more than 4 times, but only 26% were eating peanut more than once per week. 27 (4.5%) reported a reaction to peanut (median age 7.4 months). CONCLUSIONS: There has been a striking shift towards earlier peanut introduction, with introduction by one year three-fold more common in 2018 compared to [2007] [2008] [2009] [2010] [2011] . The impact of this shift on the population prevalence of peanut allergy will be assessed at completion of the EarlyNuts study.
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